MDMA-D5 HFB
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | 9yze0xHSp2O |
|---|---|
| InChI | InChI=1S/C15H14F7NO3/c1-8(5-9-3-4-10-11(6-9)26-7-25-10)23(2)12(24)13(16,17)14(18,19)15(20,21)22/h3-4,6,8H,5,7H2,1-2H3/i2D3,5D,8D |
| InChIKey | ZGHICVNRTPSTFX-RMOCDOLISA-N |
| Mol Weight | 394.3 g/mol |
| Molecular Formula | C15H9D5F7NO3 |
| Exact Mass | 394.117574 g/mol |
| Copyright | Copyright © 2023-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | H.H.Maurer, M.Meyer, K.Pfleger, A.A. Weber / University of Saarland, D-66424 Homburg Germany |
| Technique | GC/MS |
MBDB-D5 PFP
2,2,2-trifluoro-N-(1,1,2,2,2-pentadeuterioethyl)-N-[1,2,2,2-tetradeuterio-1-[deuterio-[3-(trifluoromethyl)phenyl]methyl]ethyl]acetamide
[1.alpha.(R*),2.beta.,5.alpha.]-5-Methyl-2-(1'-methylethyl)cyclohexyl-[3aR,7R,7aS]-7-(1',3'-benzodioxol-5'-yl)-octahydro-1H-indole-1-carboxylate
3,4-CTMP HFBA derivative
6,7,9-Trimethoxy-8-methyl-1,2,3,5,10,10a-hexahydrobenz[f]indolizine
2-(Benzo[d][1,3]dioxol-5-yl)-N-(tert-butyl)-2-(3-oxo-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)acetamide
(1R*,11bR*)-9,10-Dimethoxy-1-methyl-1,6,7,11b-tetrahydro-2H,4H-[1,3]oxazino-[4,3-a]isoquinolin-4-one
benzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one, 5,6,7,8-tetrahydro-3-[[(E)-(5-methyl-2-furanyl)methylidene]amino]-
N-(tert-Butoxycarbonyl)-2-(3,4-dimethoxyphenyl)-5-methyl-1-[(phenylmethoxy)carbonyl]-3-piperidineamine
Butanoic acid, heptafluoro-, 4-[1-(2,2,3,3,4,4,4-heptafluoro-1-oxobutoxy)-2-[(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)methylamino]ethyl]-2-methoxyphenyl ester
This compound is available in the following databases:
Maurer, Meyer, Pfleger, Weber: GC-MS Library of Drugs, Poisons, and Their Metabolites 6th Edition
Author: Hans H. Maurer, Markus Meyer, Karl Pfleger, Armin A. Weber
Identification of trace drugs, poisons, and pollutants requires broad coverage of specific compound classes: metabolites, acetylated, methylated, trimethylsilylated, trifluoroacetylated, pentafluoropropionylated, and heptafluorobutyrylated compounds. Learn more.